Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: Soc Psychiatry Psychiatr Epidemiol. 2022 Mar 9:10.1007/s00127-022-02249-3. doi: 10.1007/s00127-022-02249-3

Table 4.

Predictors of helpful treatment and persistence (pooled across professionals seen), and predictors of perceived helpfulness of treatment (person level), among people with lifetime DSM-IV social anxiety disorder (SAD) who obtained treatment

Model 1: Predicting helpful treatment pooled across professionals seen (n=3180)
Model 2: Predicting persistence pooled across treatment failure (n=2324)
Model 3: Predicting perceived helpfulness of treatment across SAD patients (n=1322)
Prevalence Multivariate Prevalence Multivariate Prevalence Multivariate



Mean/% (SE) AOR (95% CI) Mean/% (SE) AOR (95% CI) Mean/% (SE) AOR (95% CI)



Age
 Age at first SAD treatment 30.1 (0.5) 1.01 (1.00-1.02) 29.8 (0.5) 1.01 (0.99-1.02) 30.6 (0.4) 1.01 (0.99-1.03)
    χ21 (p-value) 1.1 (0.29) 1.1 (0.28) 0.9 (0.35)
Gender
 Female 59.1 (2.5) 1.25* (1.03-1.52) 58.0 (2.9) 0.98 (0.74-1.30) 60.4 (1.5) 1.20 (0.88-1.65)
 Male 40.9 (2.5) 1.0 42.0 (2.9) 1.0 39.6 (1.5) 1.0
    χ21 (p-value) 5.3 (0.021)* 0.0 (0.87) 1.3 (0.26)
Marital Status
 Never married 51.8 (1.9) 0.95 (0.76-1.19) 52.0 (2.2) 0.72 (0.51-1.02) 53.8 (1.2) 0.68* (0.47-0.98)
 Previously married 18.5 (1.4) 0.64* (0.48-0.84) 19.3 (1.7) 0.82 (0.52-1.28) 17.0 (1.1) 0.53* (0.33-0.83)
 Currently married 29.7 (2.3) 1.0 - 28.7 (2.8) 1.0 - 29.1 (1.2) 1.0 -
    χ22 (p-value) 11.7 (0.003)* 3.4 (0.18) 8.8 (0.012)*
Education
 Low 8.4 (0.9) 0.96 (0.69-1.33) 8.1 (1.0) 0.77 (0.49-1.21) 9.5 (1.0) 0.86 (0.55-1.35)
 Low-average 19.1 (1.7) 0.86 (0.65-1.12) 19.1 (1.9) 1.08 (0.71-1.65) 18.3 (1.1) 0.95 (0.61-1.47)
 High-average 37.0 (2.1) 0.80* (0.65-0.99) 37.2 (2.4) 1.25 (0.88-1.76) 35.2 (1.3) 0.95 (0.66-1.39)
 Student 17.6 (1.6) 0.59* (0.45-0.78) 19.1 (1.9) 1.31 (0.84-2.05) 16.3 (1.1) 0.76 (0.47-1.23)
 High 18.0 (1.3) 1.0 - 16.5 (1.4) 1.0 - 20.7 (1.2) 1.0 -
    χ24 (p-value) 14.9 (0.005)* 5.7 (0.22) 1.7 (0.79)
Treatment delay (years)a 14.6 (0.5) 1.01 (1.00-1.02) 14.2 (0.6) 0.98* (0.97-0.99) 15.5 (0.4) 0.99 (0.98-1.01)
    χ21 (p-value) 3.2 (0.07) 10.2 (0.001)* 1.0 (0.33)
Started SAD treatment >= 2000 (vs. 1990-1999) 42.3 (2.2) 1.59* (1.34-1.89) 39.4 (2.5) 0.63* (0.49-0.83) 50.0 (1.6) 1.01 (0.77-1.32)
    χ21 (p-value) 27.8 (<.001)* 11.3 (<.001)* 0.0 (0.96)
Treatment Typeb
 Mental health specialist + Psychotherapy 64.2 (1.9) 0.76* (0.58-0.99) 64.6 (2.1) 1.27 (0.85-1.90) 61.9 (1.5) 0.92 (0.60-1.42)
 Mental health specialist + Medication 69.2 (1.8) 0.66* (0.52-0.85) 71.4 (1.8) 1.83* (1.31-2.56) 57.9 (1.6) 1.23 (0.85-1.79)
 General medical 73.9 (1.7) 0.64* (0.50-0.82) 75.7 (1.9) 0.94 (0.66-1.35) 68.5 (1.3) 0.67* (0.48-0.93)
 Complementary/alternative medicine 32.3 (2.2) 0.86 (0.70-1.06) 33.5 (2.6) 1.35 (0.97-1.88) 26.0 (1.2) 1.11 (0.78-1.57)
 Human services 20.9 (2.4) 1.0 - 22.7 (2.8) 1.0 - 15.2 (1.1) 1.0 -
    χ24 (p-value) 17.5 (0.002)* 20.6 (<.001)* 9.5 (0.05)
 Exactly 2 or more of the above 78.4 (1.5) 1.37 (0.94-2.00) 79.6 (1.7) 1.80* (1.15-2.82) 69.3 (1.5) 1.81* (1.06-3.10)
    χ21 (p-value) 2.7 (0.10) 6.7 (0.010)* 4.7 (0.031)*
    χ25 (p-value) 21.8 (<.001)* 73.0 (<.001)* 21.9 (<.001)*
Number of lifetime anxiety disordersc
 3 or morec 40.1 (2.2) 0.87 (0.70-1.08) 41.8 (2.6) 2.32* (1.72-3.12) 32.0 (1.2) 1.83* (1.30-2.57)
 Exactly 2c 32.1 (1.9) 1.13 (0.94-1.37) 31.0 (2.1) 1.41* (1.04-1.90) 34.1 (1.4) 1.50* (1.09-2.06)
 Exactly 1c 27.9 (1.7) 1.0 - 27.2 (1.8) 1.0 - 34.0 (1.4) 1.0 -
    χ22 (p-value) 7.3 (0.027)* 31.5 (<.001)* 14.5 (<.001)*
Mood disorder
 Major depressive disorder 42.5 (2.1) 1.01 (0.84-1.21) 42.1 (2.5) 1.22 (0.91-1.63) 40.5 (1.4) 1.23 (0.91-1.67)
 Bipolar disorder 14.9 (2.4) 0.84 (0.63-1.14) 16.3 (3.0) 0.87 (0.61-1.24) 11.7 (0.80 0.84 (0.56-1.29)
Substance use disorder
    χ22 (p-value) 1.3 (0.51) 3.4 (0.18) 3.2 (0.20)
 Alcohol and/or drug abuse 26.8 (2.6) 1.04 (0.81-1.32) 27.6 (3.2) 1.11 (0.78-1.57) 23.8 (1.3) 1.12 (0.77-1.64)
 Alcohol or drug dependence but not abuse 3.9 (0.9) 0.73 (0.45-1.17) 4.4 (0.8) 1.55 (0.94-2.57) 2.7 (0.4) 0.92 (0.48-1.78)
    χ22 (p-value) 2.1 (0.35) 3.0 (0.23) 0.6 (0.74)
    χ26 (p-value) 13.9 (0.031)* 41.7 (<.001)* 17.8 (0.007)*
Childhood Adversities
 Family Dysfunctiond 34.7 (2.3) 0.80* (0.65-0.98) 35.8 (2.7) 0.80 (0.59-1.10) 33.7 (1.3) 0.64* (0.46-0.88)
 Othere 18.2 (2.5) 0.95 (0.69-1.30) 18.6 (3.2) 1.18 (0.82-1.69) 16.8 (1.1) 1.06 (0.69-1.61)
    χ22 (p-value) 5.4 (0.07) 2.0 (0.38) 8.0 (0.018)*
Global χ223 132.1 (<.001)* 326.2 (<.001)* 85.6 (<.001)*

Abbreviations: SE, standard error; AOR, adjusted odds ratio; CI, confidence interval.

*

Significant at .05 level, two-sided test.

a

Treatment delay (years) = Age at first SAD treatment – Age at onset of SAD.

b

Treatment providers: mental health specialists (psychiatrist, psychiatric nurse, psychologist, psychiatric social worker, mental health counselor), primary care providers, human services providers (social worker or counselor in a social services agency, spiritual advisor), and complementary/alternative medicine (other type of healer or self-help group).

c

Lifetime anxiety disorders include generalized anxiety disorder, panic disorder, agoraphobia with or without panic disorder, post-traumatic stress disorder, specific phobia and social anxiety disorder.

d

Family Dysfunction includes Physical abuse, Sexual abuse, Neglect, Parent mental disorder, Parent substance use disorder, Parent criminal behavior and Family violence.

e

Other includes Parent death, Parent divorce, Other loss of a parent, Physical illness and Economic adversity.